CD34 and Fabry disease: The primary objectives of this study were to determine the safety and toxicity of autologous stem cell transplantation with mobilized CD34+ hematopoietic cells transduced with a lentiviral vector containing human codon-optimized α-gal A cDNA in adult male Fabry disease patients.